The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the ...

ENCELTOTM (revakinagene taroretcel-lwey) is approved in the United States for the treatment of adults ... eye wall resulting in vision loss), vitreous hemorrhage (bleeding within the central ...

The aim of the treatment in ocular BD is to achieve ... should be performed to prevent complications, such as vitreous hemorrhage and neovascular glaucoma. Although variable, the prognosis of ...

vitreous hemorrhage among others) SL Galetta has received consulting honoraria from Biogen Idec and Teva Parmaceuticals. The authors have no other relevant affiliations or financial involvement ...

The hypothesis that systolic blood pressure reduction in acute intracerebral hemorrhage increases the incidence of ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

In this role, Beth will lead the commercial organization, including preparing for the U.S. launch of ENCELTO TM (revakinagene taroretcel-lwey), the first and only approved treatment for adults ...

In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion. The FDA issued a complete response ...

Francis called Trump's mass deportation policy a "disgrace." President Donald Trump on Monday offered brief condolences over the passing of Pope Francis, but the two men clashed repeatedly ...